In this episode, Dean Calhoun of Affygility Solutions discusses top 10 mistakes & tricks used by cheap providers of PDE reports.

Occupational Toxicology and Occupational Medicine - Where are they the same and where are they different? In this episode of the BioPharma EHS Podcast, Dean M. Calhoun, President and CEO of Affygility Solutions hosts a discussion between Dr. Mark Cunningham-Hill, President of Worldwide Health Consulting LLC and Dr. Frank Richardson, Principal Toxicologist for Affygility Solutions LLC. The discussion starts out covering the basic elements of an occupational medicine program and the unique...

In Episode #24 of the Biopharma EHS podcast, Dean M. Calhoun, CIH discusses with Dr. Joe Nieusma, Senior Occupational Toxicologist for Affygility Solutions, the "Mystery of Cytotoxic Compounds." For multi-product pharmaceutical manufacturing facilities, this often a controversial topic since many people believe that cytotoxic compounds require dedicated facilities or equipment. It is also a topic of debate when setting occupational exposure limits and acceptable daily exposure values for...

In this episode of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions interviews Kevin Rosenthal of Pharmatek Laboratories. During the interview we discuss handling potent compounds, potent compound safety, and occupational control banding. Dean Calhoun also responds to the frequently asked question, "What type of equipment do I need to handle a highly potent compound?"   If you would like to learn more, visit affygility.com

In this episode of the Biopharma EHS Podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions, interviews Ms. Stephanie Wilkins, President of PharmaConsult US, on the subject of Risk-MaPP, ADEs and PDEs: Their importance to multi-product pharmaceutical manufacturing facilities. Risk-MaPP stands for Risk-Based Manufacture of Pharmaceutical Products. It is one of the International Society of Pharmaceutical Engineers' (ISPE) Base-line Guides. One of the essential components of...

BioPharma EH&S Podcast Episode No. 20 Hello everybody and welcome back to another Episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biopharma industry, helping you take your environmental, health and safety programs to the next level.  Well, it’s Sunday, July 14th, 2013 and it’s great to be here today. We have great show in store for you...

In this podcast, Dean M. Calhoun of Affygility Solutions discusses four key technologies or trends that will have a significant impact on the pharmaceutical industry for the next 100 years. These trends include: the development of medicines in space, the Internet of Things, the Maker movement, and the use of Big Data tools. He will also discuss taking leaps forward and barriers that we will encounter.

In this presentation, Dean M. Calhoun, CIH, with certification in industrial hygiene by the American Board of Industrial Hygiene (ABIH) discusses the key concepts and principles that need to be considered when auditing biotechnology and pharmaceutical facilities for potent compound safety issues. His talk was presented at the World Highly Potent Active Pharmaceutical Ingredient Summit in Philadelphia, PA in June of 2012. If you have any questions regarding potent compound safety, EHS...

Nanotechnology and the Pharmaceutical Industry - an interview with Don Ewert of OSO Biopharmaceuticals. Hello everybody and welcome back to another episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biopharma industry, helping you take your environmental, health and safety programs to the next level. Overview I’ll briefly cover what we talked...

Containment Validation and Surrogate Monitoring In this episode of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions discusses the following topics: A review of Episode no. 16 of the Biopharma EHS podcast.  In that episode, Dean M. Calhoun, President and CEO of Affygility Solutions, and Dr. Joe Nieusma, Sr. Occupational Toxicologist with Affygility Solutions discuss Category 4 and 5 potent compounds.  Our discussions include what factors determine a...

In this podcast, Dean M. Calhoun, CIH and Joe Nieusma, Ph.D. of Affygility Solutions discuss Category 4 and Category 5 Potent Compounds - Understanding the Risks. Items covered include: Review of the last podcast What factors go into determining an active pharmaceutical ingredients as a Category 4 or Category 5 potent compound We provide examples of Category 4 and Category 5 potent compounds Review upcoming events and happenings related to environmental, health and safety in the...

0 0 1 884 5041 Affygility Solutions 42 11 5914 14.0 Normal 0 false false false EN-US JA X-NONE ...

Our main topic for today is the Young Guns of Environmental, Health and Safety     [listen to podcast for details]   Alright, that does it for our main topic, let’s now talk about some upcoming events.   First I should mention, that coming up next week, we have several new webinars starting and you should look at our schedule at Affygility.com.  These webinars have been very well attended and we have received a lot of positive feedback on them.  In addition to our very popular webinar...

In this podcast, Dean Calhoun of Affygility Solutions discusses Social Media and Environmental, Health and Safety The twitter hashtag for today’s podcast is #socialehs    First, I’ll briefly cover what we talked about last time in episode number 12    Then I will cover our main topic for today, which is the use of Social Media in Environmental, Health and Safety industry.    And finally, I’ll then discuss upcoming events and happenings of importance to environmental, health and safety...

BioPharma EH&S Podcast Episode No. 12.  Saturday, March 5th, 2011 and we have so much to talk about today, so I’m going to get right into it. First off, I’ll briefly cover what we talked about last time in episode number 11 Main topic for today :“Creeping Featurism in Environmental, Health and Safety software”, which I’m quite certain sure will stir up some controversy. Last time in Episode 11 we discussed the topic of “The Evolution of EHS Compliance and Operational Risk Management...

BioPharma EH&S Podcast Episode #11 Discuss: The Evolution of Environmental, Health and Safety Compliance and Operational Risk Management Software Upcoming Events and Happenings of Importance to Environmental, Health and Safety professionals in the BioPharma industry. Hello everybody and welcome back to the Biopharma EH&S Podcast, Episode #11, it's Saturday, February 26th, 2011.  And this is the podcast helping you take your environmental, health and safety program to the next...

  BioPharma EH&S Podcast Episode No. 10 Note: This is the abbreviated script of the podcast, for the more detailed version go to http://potentcompoundsafety.com/?p=642 Cover what we talked about last time in episode number 9 Then I will cover our main topic for today, which is “Industrial hygiene in the pharmaceutical industry.” Discuss upcoming events and happenings of importance to environmental, health and safety professionals in the BioPharma Industry. Discussed the topic of...

  Biopharma EHS Podcast Episode #9 Opening So for today, first off, I'll mention what we discussed last time, then we I'll cover our main topic for today - which is how to be a road warrior of environmental, health and safety, and then finally, I will mention important upcomings and happenings that are applicable to environmental, health and safety professionals in the Biopharma industry. So, in our last podcast, episode 8, I discussed the future of EH&S.  Now, when I'm talking about...

0 0 1 1630 9291 Affygility Solutions 77 21 10900 14.0 Normal 0 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table...

Management Commitment and Involvement - How to obtain it and sustain it for your EHS Program. Introduction.   Review last time.   Main topic: "Management Commitment – how to obtain and sustain it.”   Upcoming events and happenings of importance to environmental, health and safety professionals in the BioPharma Industry.   Important announcement to talk about and I’m very excited about this, and I believe you will be too.   Episode 6 we discussed some of key regulatory agenda...

I2P2 and GHS - important OSHA regulatory issues for 2011.  In this episode of the BioPharma EHS podcast, Dean M. Calhoun, CIH - President and CEO of Affygility Solutions discusses two of OSHA's regulatory issues for the calendar year 2011 that will effect the biotechnology and pharmaceutical industry.  The first issue is OSHA's Injury and Illness Prevention Program, and the second is the Global Harmonization System for Classifying and Labeling Chemicals. In you have a question regarding an...

In this episode of the BioPharma EHS Podcast, the top 10 OSHA violations in the biotechnology and pharmaceutical industry are discussed by Dean M. Calhoun, CIH, President and CEO of Affygility Solutions.  These common violations include the respiratory protection standard, hazard communication, lockout/tagout, machine guarding, electrical, walking surfaces/space, and occupational exposure to hazardous chemicals in laboratories.  In order to avoid these types of violations, companies of all...